AI in Medical Imaging Market Size- By Technology, By Application, By Modalities, By End Use- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

AI in Medical Imaging Market Introduction and Overview

According to SPER market research, 'Global AI in Medical Imaging Market Size- By Technology, By Application, By Modalities, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global AI in Medical Imaging Market is predicted to reach 20.84 billion by 2033 with a CAGR of 34.9%.

The term artificial intelligence (AI) in medical imaging describes the application of AI technologies, namely machine learning and deep learning, to improve the management, interpretation, and analysis of medical images. By using imaging data from MRIs, CT scans, ultrasounds, and X-rays, these technologies allow for the automated identification, diagnosis, and prognosis of a variety of medical disorders.

AI's adoption in the worldwide medical imaging market was further driven by the COVID-19 pandemic. The need for AI-driven solutions increased as the world's healthcare systems encountered previously unheard-of difficulties, especially in areas like diagnosis, imaging workflow optimization, and patient triage. Physicians were able to swiftly and precisely evaluate medical pictures, including chest X-rays and CT scans, using AI technology to identify pneumonia symptoms linked to COVID-19 and other conditions.\

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Technology, By Application, By Modalities, By End Use.

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Companies Covered

Advanced Micro Devices, Inc. (AMD), Butterfly Network, Inc., Canon Medical Systems USA, Inc., Digital Diagnostics Inc., EchoNous, Inc., Enlitic, Inc., Exo Imaging, Inc., GE HealthCare, HeartFlow, Inc., Microsoft, Nano-X Imaging Ltd, TEMPUS, Viz.ai, Inc., Others.

AI in Medical Imaging Market Segmentation:

By Technology: Based on the Technology, Global AI in Medical Imaging Market is segmented as; Deep Learning, Natural Language Processing, Computer Vision, Other.

By Application: Based on the Application, Global AI in Medical Imaging Market is segmented as; Neurology, Respiratory and Pulmonary, Cardiology, Breast Screening, Orthopaedics, Others.

By Modalities: Based on the Modalities, Global AI in Medical Imaging Market is segmented as; CT Scan, MRI, X-rays, Ultrasound, Nuclear Imaging.

By End Use: Based on the End Use, Global AI in Medical Imaging Market is segmented as; Hospitals, Diagnostic Imaging Centers, Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Product Code: IACT2501

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global AI in Medical Imaging Market.

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global AI in Medical Imaging Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global AI in Medical Imaging Market

7. Global AI in Medical Imaging Market, By Technology (USD Million) 2024-2030

7.1. Deep Learning
7.2. Natural Language Processing (NLP)
7.3. Computer Vision
7.4. Others

8. Global AI in Medical Imaging Market, By Application (USD Million) 2024-2030

8.1. Neurology
8.2. Respiratory and Pulmonary
8.3. Cardiology
8.4. Breast Screening
8.5. Orthopaedics
8.6. Others

9. Global AI in Medical Imaging Market, By Modalities (USD Million) 2024-2030

9.1. CT scan
9.2. MRI
9.3. X-rays
9.4. Ultrasound
9.5. Nuclear Imaging

10. Global AI in Medical Imaging Market, By End Use (USD Million) 2024-2030

10.1. Hospitals
10.2. Diagnostic Imaging Centers
10.3. Others

11. Global AI in Medical Imaging Market Forecast, 2024-2030 (USD Million)

11.1. Global AI in Medical Imaging Market Size and Market Share

12. Global AI in Medical Imaging Market, By Region, 2024-2030 (USD Million)

12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America

13. Company Profile

13.1. Advanced Micro Devices, Inc. (AMD)
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. Butterfly Network, Inc.
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. Canon Medical Systems USA, Inc.
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. Digital Diagnostics Inc.
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. EchoNous, Inc.
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. Enlitic, Inc.
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. Exo Imaging, Inc.
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. GE HealthCare
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. HeartFlow, Inc.
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Microsoft
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
13.11. Nano-X Imaging Ltd
- 13.11.1. Company details
- 13.11.2. Financial outlook
- 13.11.3. Product summary
- 13.11.4. Recent developments
13.12. TEMPUS
- 13.12.1. Company details
- 13.12.2. Financial outlook
- 13.12.3. Product summary
- 13.12.4. Recent developments
13.13. Viz.ai, Inc.
- 13.13.1. Company details
- 13.13.2. Financial outlook
- 13.13.3. Product summary
- 13.13.4. Recent developments
13.14. Others